Business
CSL : Seqirus Signs Long-Term Agreement with the Pan American Health Organization (PAHO) to Advance Pandemic Influenza Preparedness in Latin America and the Caribbean
CSL : Seqirus Signs Long-Term Agreement with the Pan American Health Organization (PAHO) to Advance Pandemic Influenza Preparedness in Latin America and the
About this update from Csl Limited
CSL Seqirus Signs Long-Term Agreement with the Pan American Health Organization (PAHO) to Advance Pandemic Influenza Preparedness in Latin America and the Caribbean A new long-term pandemic preparedness agreement between CSL Seqirus and PAHO's Regional Revolving Fund builds on the parties' seasonal influenza collaboration to support rapid and scalable pandemic response. CSL Seqirus will leverage its global influenza manufacturing network and work with Sinergium Biotech to support regional fill-finish and distribution capabilities across Latin America and the Caribbean. Agreement reflects PAHO's long-standing commitment to strengthening pandemic preparedness across its Member States in the face of emerging health threats.BUENOS AIRES, ARGENTINA, May 12, 2026 - CSL Seqirus, a business of CSL (ASX: CSL), announced it has signed a new multi-year pandemic preparedness agreement with PAHO's Regional Revolving Fund to help strengthen influenza pandemic preparedness across Latin America and the Caribbean. Under the terms of the agreement, millions of doses of pandemic influenza vaccine have been reserved with CSL Seqirus and may be ordered by participating countries across Latin America and the Caribbean in the event of an influenza pandemic. The agreement requires CSL Seqirus to be prepared to rapidly manufacture and deliver these doses to help protect against the influenza strain identified by the World Health Organization (WHO) when an influenza pandemic is declared. "A pandemic doesn't wait for us to be ready. That's exactly why agreements like this one matter," said Gonzalo Pereira, Latin America General Manager, CSL Seqirus. "By reserving doses and embedding regional manufacturing capabilities, this agreement helps strengthen regional coordination and access to pandemic vaccines across Latin America and the Caribbean when the next influenza pandemic strikes." This agreement builds on the parties' multi-year collaboration for seasonal influenza vaccine supply in the region. CSL Seqirus will work with long-term production partner Sinergium Biotech, a leading Argentine vaccine company with industrial and regulatory capabilities at its plant in Garín, Buenos Aires Province, to support regional vaccine fill-finish and distribution. Seasonal vaccine production creates an essential "warm base," ensuring staff, production lines and key manufacturing components are ...